Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 May;7(5):251-65.
doi: 10.1038/nrclinonc.2010.41. Epub 2010 Mar 30.

The molecular pathology of cancer

Timothy J R Harris  1 , Frank McCormick
Affiliations
Review

The molecular pathology of cancer

Timothy J R Harris et al. Nat Rev Clin Oncol. 2010 May.

Abstract

Rapid technical advances in DNA sequencing and genome-wide association studies are driving the discovery of the germline and somatic mutations that are present in different cancers. Mutations in genes involved in cellular signaling are common, and often shared by tumors that arise in distinct anatomical locations. Here we review the most important molecular changes in different cancers from the perspective of what should be analyzed on a routine basis in the clinic. The paradigms are EGFR mutations in adenocarcinoma of the lung that can be treated with gefitinib, KRAS mutations in colon cancer with respect to treatment with EGFR antibodies, and the use of gene-expression analysis for ER-positive, node-negative breast cancer patients with respect to chemotherapy options. Several other examples in both solid and hematological cancers are also provided. We focus on how disease subtypes can influence therapy and discuss the implications of the impending molecular diagnostic revolution from the point of view of the patients, clinicians, and the diagnostic and pharmaceutical companies. This paradigm shift is occurring first in cancer patient management and is likely to promote the application of these technologies to other diseases.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cancer Cell. 2008 Jan;13(1):48-57 - PubMed
    1. N Engl J Med. 2003 May 1;348(18):1777-85 - PubMed
    1. Cancer Cell. 2009 Jun 2;15(6):489-500 - PubMed
    1. J Clin Oncol. 2009 Dec 1;27(34):5848-56 - PubMed
    1. Nat Rev Drug Discov. 2009 Aug;8(8):627-44 - PubMed

Publication types

MeSH terms